Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  yttrium Y 90 ibritumomab tiuxetan
Find trials that include:  Any drugs shown
Results 1-6 of 6 for your search:
Start Over
Combination Chemotherapy or 90-Yttrium Ibritumomab Tiuxetan and Combination Chemotherapy before Stem Cell Transplant in Treating Patients with Relapsed Diffuse Large B-cell Non-Hodgkin Lymphoma
Phase: Phase III
Type: Treatment
Age: 18 to 70
Trial IDs: 12338, NCI-2015-00185, 093270, 2012-0005534-11, NCT00491491, NCT02366663
Rituximab and Ibritumomab Tiuxetan in Treating Patients With Stage II-III Multiple Myeloma
Phase: Phase II
Type: Treatment
Age: 18 to 70
Trial IDs: 7306, NCI-2010-02131, NCT01207765
PET-Directed Therapy in Treating Patients with Limited-Stage Diffuse Large B-Cell Lymphoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: S1001, NCI-2011-02673, CDR0000700624, SWOG-S1001, NCT01359592
Belinostat and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed Aggressive B-Cell Non-Hodgkin Lymphoma
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 12-0288-04, NCI-2012-01131, NCT01686165
Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma
Phase: Phase II
Type: Treatment
Age: Over 18
Trial IDs: BIDMC-2004P-000044, NCI-2011-02445, NCT00110149
Start Over